These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9172870)

  • 1. [Surface-active substances in the arsenal of agents against AIDS].
    Krivoshein IuS; Krivorutchenko IuL
    Mikrobiol Z; 1997; 59(1):87-97. PubMed ID: 9172870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surfactants as agents for the individual prevention of HIV/AIDS].
    Krivorutchenko IuL
    Mikrobiol Z; 1999; 61(1):95-103. PubMed ID: 10330875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of didanosine in the management of HIV-1 infection.
    Gazzard BG; Moyle GJ
    Antivir Ther; 1997 Jul; 2(3):135-47. PubMed ID: 11322269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental and clinical research of HIV-1 resistance in three AIDS patients who had experienced multiple regimens.
    Lu JF; Li J; Li HP; Liu SY; Zhuang DM; Liu YJ; Bao ZY; Li L; Wu H; Li JY
    Chin Med J (Engl); 2009 Mar; 122(6):752-4. PubMed ID: 19323948
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of HIV-1 integrase by small molecules: the potential for a new class of AIDS chemotherapeutics.
    Young SD
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):402-10. PubMed ID: 11727305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-AIDS agents 66: syntheses and anti-HIV activity of phenolic and aza 3',4'-di-O-(-)-camphanoyl-(+)-cis-khellactone (DCK) derivatives.
    Suzuki M; Yu D; Morris-Natschke SL; Smith PC; Lee KH
    Bioorg Med Chem; 2007 Nov; 15(21):6852-8. PubMed ID: 17719228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review. Drug resistance of human immunodeficiency virus and overcoming it by natural products.
    Hupfeld J; Efferth T
    In Vivo; 2009; 23(1):1-6. PubMed ID: 19368117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral drugs in the treatment of AIDS: what is in the pipeline ?
    Stellbrink HJ
    Eur J Med Res; 2007 Oct; 12(9):483-95. PubMed ID: 17933730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current developments in anti-HIV/AIDS gene therapy.
    Tsygankov AY
    Curr Opin Investig Drugs; 2009 Feb; 10(2):137-49. PubMed ID: 19197791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Battling AIDS.
    Nat Struct Biol; 1999 Oct; 6(10):895-6. PubMed ID: 10504715
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antiretroviral therapy of acquired immunodeficiency syndrome (AIDS)].
    Jevtović Dj; Ranin J; Salemović D; Brmbolić B; Zerjav S
    Srp Arh Celok Lek; 1992 Nov; 120 Suppl 5():38-41. PubMed ID: 18170976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-AIDS agents. Part 57: Actein, an anti-HIV principle from the rhizome of Cimicifuga racemosa (black cohosh), and the anti-HIV activity of related saponins.
    Sakurai N; Wu JH; Sashida Y; Mimaki Y; Nikaido T; Koike K; Itokawa H; Lee KH
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1329-32. PubMed ID: 14980692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current treatment of HIV infection].
    Blaxhult A; Lidman K
    Nord Med; 1998 Nov; 113(9):290-2, 296. PubMed ID: 9835758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing anti-AIDS drugs targeting the major mechanism of HIV-1 RT resistance to nucleoside analog drugs.
    Sarafianos SG; Hughes SH; Arnold E
    Int J Biochem Cell Biol; 2004 Sep; 36(9):1706-15. PubMed ID: 15183339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [AIDS: new developments. VI. HIV reservoirs during intensive antiretroviral treatment].
    Notermans DW; Danner SA; de Wolf F; Lange JM
    Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1909-12. PubMed ID: 9856176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic aspects of HIV/AIDS infected patients and evaluation of therapeutic protocols].
    Reszketö Z; Szlávik J; Balogh J; Vincze Z
    Acta Pharm Hung; 2001 Dec; 71(4):428-32. PubMed ID: 12113183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.
    Van Vaerenbergh K; Debaisieux L; De Cabooter N; Declercq C; Desmet K; Fransen K; Maes B; Marissens D; Miller K; Muyldermans G; Sprecher S; Stuyver L; Vaira D; Verhofstede C; Zissis G; Van Ranst M; De Clercq E; Desmyter J; Vandamme AM
    Antivir Ther; 2001 Mar; 6(1):63-70. PubMed ID: 11417763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New era in AIDS therapy with highly active anti-retroviral agents].
    Maayan S
    Harefuah; 1998 Feb; 134(3):190-3. PubMed ID: 9662910
    [No Abstract]   [Full Text] [Related]  

  • 19. 25 years of HIV/AIDS science: reaching the poor with research advances.
    Fauci AS
    Cell; 2007 Nov; 131(3):429-32. PubMed ID: 17981106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New ammunition in the battle against AIDS].
    Agosto M
    Sidahora; 1997; ():25-6. PubMed ID: 11364803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.